Infibeam Avenues Ltd is a fintech company specializing in digital payment solutions and enterprise software. With CCAvenue, Infibeam provides over 250 payment options in India and supports international transactions in 27 currencies. Additionally, it caters to specific industries through platforms like GeM, BillAvenue, and ResAvenue. The company recently invested approximately INR. 1.2 billion in international markets during the first half of FY24, focusing primarily on data localization, security, and IP rights, all funded through internal accruals. This reflects the company’s willingness to establish itself as a major player in the AI-based fraud detection and prevention market. Additionally, it has invested around INR 1 billion in creating a new AI Hub, expanding its operations from its existing GIFT City hub.

Infibeam’s AI arm, Phronetic.AI, scored big on August 28th, 2024, by securing contracts for its “AI Facility Manager” with both hospitals and a gas station chain. Powered by Theia Vision AI technology, this system promises significant benefits for each client. While the hospitals can benefit from improved diagnostics and real-time patient monitoring, leading to faster and more effective treatments, the UAE-based gas stations can enhance security, streamline operations, and potentially improve customer service with real-time threat detection, automated transaction monitoring, and customer behavior analysis.

Although the company is trading above the industry P/E, the stock looks poised for a good return. Net sales reached ₹752.75 crore in June 2024, reflecting a 1.4% increase from ₹742.36 crore in June 2023. Quarterly net profit surged to ₹ 70.02 crore in June 2024, marking a significant 168.69% rise from ₹26.06 crore in June 2023. EBITDA also saw strong growth, rising 86.16% to ₹96.15 crore in June 2024 from ₹51.65 crore in the same period last year. Infibeam Avenue’s EPS increased to ₹0.25 in June 2024, up from ₹0.09 in June 2023.

Technically, Infibeam Avenues appears poised for a rebound. It has found support at the 200-day moving average (DMA) and may soon break above the 50-DMA. The stock has been consolidating steadily above the 44-day SMA for the past month, and the Relative Strength Index (RSI) is currently in a neutral zone.

At its current price of 31, Infibeam Avenues offers a potentially attractive entry point for long-term investors. The stock’s price has found support at 27, suggesting a solid base for further accumulation. Given the company’s promising growth prospects, this could be a rewarding investment opportunity.